Stay updated on InMed Pharmaceuticals Press Releases

Sign up to get notified when there's something new on the InMed Pharmaceuticals Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the InMed Pharmaceuticals Press Releases page

  1. Check
    today
    Change Detected
    Summary
    InMed has announced the results of its 2024 Annual General Meeting and entered into a Standby Equity Purchase Agreement, while recent financial results and an executive appointment have been removed from the site.
    Difference
    11%
    Check dated 2024-12-22T01:56:26.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    InMed has announced the publication of a study on anti-inflammation through modulation of the endocannabinoid system, while previous announcements regarding a fireside chat on the pharmaceutical pipeline have been removed.
    Difference
    9%
    Check dated 2024-11-23T04:42:43.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    InMed has reported its first quarter fiscal 2025 financial results and announced a share consolidation to comply with Nasdaq listing rules, while previous updates regarding 2024 milestones and the results of the 2023 annual general meeting have been removed.
    Difference
    10%
    Check dated 2024-11-15T23:51:16.000Z thumbnail image
  7. Check
    43 days ago
    Change Detected
    Summary
    InMed Pharmaceuticals has announced a decision by the NASDAQ Hearings Panel to grant an exception for a share consolidation, while a previous announcement regarding the expansion of its pharmaceutical pipeline has been removed.
    Difference
    9%
    Check dated 2024-11-08T18:30:20.000Z thumbnail image
  8. Check
    51 days ago
    Change Detected
    Summary
    InMed Pharmaceuticals has filed an additional patent application for INM-901 targeting neurodegenerative conditions, including Alzheimer's disease, while the previous report on their first quarter fiscal 2024 financial results has been removed.
    Difference
    7%
    Check dated 2024-11-01T10:54:52.000Z thumbnail image
  9. Check
    58 days ago
    Change Detected
    Summary
    InMed is set to participate in a webinar on neuroinflammation related to Alzheimer's disease and has appointed Dr. Barry Greenberg to its Scientific Advisory Board, while recent announcements about a clinical study presentation and a private placement have been removed.
    Difference
    98%
    Check dated 2024-10-25T00:49:47.000Z thumbnail image

Stay in the know with updates to InMed Pharmaceuticals Press Releases

Enter your email address, and we'll notify you when there's something new on the InMed Pharmaceuticals Press Releases page.